InvestorsHub Logo

Amigo Mike

11/20/15 10:45 AM

#4655 RE: weazelboy #4654

Agreed,

L2 has flipped from prior weeks ...... to the sell side of the equation.

Yes it is petty cash ... regardless of the number .... for any major pharma. Even a much smaller pharma could swallow this with relative ease.

Funny thing .... I'm certain there is interest in the "science" and product. If that is true, why aren't Dahl/Rice executing ????

Amigo Mike